CONDITION
Copper-Associated Hepatopathy
Copper-associated hepatopathy describes a group of conditions in which copper accumulates in the liver to levels that damage the tissue. Copper is a necessary trace element, but when the body cannot regulate or excrete it properly — whether because of an inherited defect in copper metabolism, dietary imbalance, or underlying liver disease — it builds up and becomes toxic to liver cells over time. Many dogs show no outward signs for months or years, and copper accumulation may be discovered incidentally during blood tests or investigation of vague signs such as reduced appetite, weight loss, or lethargy. In other cases, the liver damage progresses to cause more pronounced signs including jaundice (yellowing of the gums and whites of the eyes), vomiting, increased thirst, or fluid accumulation in the abdomen. Some breeds, particularly Bedlington Terriers, Labrador Retrievers, and Dobermanns, carry inherited variants that affect copper handling, though the condition appears across many breeds and in dogs without a known genetic predisposition. The page that follows explores what signs may prompt investigation, what happens inside the liver as copper accumulates, how the condition is diagnosed — including the role of biopsy and genetic testing — and the range of approaches used to manage copper levels and support liver function over time.
Why this matters now
Copper-associated hepatopathy tends to affect young to middle-aged dogs, with many animals showing initial clinical signs between two and six years of age, though the underlying accumulation often begins much earlier. Certain breeds carry well-characterised genetic mutations — Bedlington Terriers with the COMMD1 defect and Labrador Retrievers with an ATP7B variant that drives copper accumulation, partially offset by a separate modifying ATP7A variant — that shape primary copper storage from birth, whilst secondary copper accumulation can develop in any breed following chronic liver inflammation or cholestatic disease. Dietary copper intake, water quality, and the copper content of commercial foods may influence the rate of accumulation in genetically predisposed animals, though the genetic defect remains the dominant driver in affected breeds.
The condition typically evolves over months to years, with copper building silently in hepatocytes long before clinical signs emerge. Some dogs remain asymptomatic well into middle age, their liver compensating until a threshold of damage is crossed, whilst others develop jaundice, weight loss, or collapse relatively early. The speed of progression varies widely between individuals and breeds; Bedlington Terriers with two copies of the COMMD1 mutation often accumulate copper more rapidly than dogs with secondary disease, though even within a breed the clinical course can differ markedly.
Signals & patterns
Early signals
Reduced appetite or pickiness
An owner may notice the dog becoming less enthusiastic about meals, leaving food in the bowl, or showing interest only in certain textures or flavours. This pattern can wax and wane over weeks and often precedes other visible changes.
Intermittent vomiting or nausea
Episodes of vomiting bile or undigested food, sometimes in the early morning, can appear sporadically. The dog may also show subtle signs of nausea such as lip-licking, drooling, or swallowing repeatedly without eating.
Gradual weight loss
Weight may decline slowly over months, often masked by a normal appetite in the early stages. The loss can be subtle enough that it becomes apparent only when comparing the dog to photographs from several months earlier.
Increased thirst or urination
Some dogs drink more water than usual and need to urinate more frequently, a pattern that can reflect the liver's reduced ability to process certain metabolic byproducts. This change is nonspecific and overlaps with many other conditions.
Later signals
Jaundice in gums or eyes
A yellow tinge becomes visible in the whites of the eyes, the gums, or the inside of the ear flaps, signalling that bilirubin is accumulating in the bloodstream. This change often prompts the first clinic visit in dogs that were previously asymptomatic.
Abdominal distension or discomfort
Fluid may accumulate in the abdomen (ascites) as liver function declines, giving the belly a rounded or pendulous appearance. The dog may become reluctant to lie down normally or show discomfort when the abdomen is touched.
Neurological changes
In advanced cases, toxins that the liver can no longer clear may affect the brain, leading to disorientation, pacing, pressing the head against walls, or altered behaviour. These signs tend to appear late and indicate significant loss of liver function.
Click to read about the biological mechanisms
How this is usually investigated
Investigation typically begins with a review of the dog's history, breed, and any clinical signs, followed by blood tests that may reveal changes in liver enzyme activity or liver function. If those initial tests suggest liver involvement, further imaging and ultimately liver biopsy with copper quantification are often undertaken to confirm whether copper accumulation is present and to assess the degree of liver damage. The sequence and selection of tests tends to be shaped by what emerges at each stage.
Blood biochemistry
Abdominal ultrasonography
Liver biopsy with histopathology and copper quantification
Genetic testing
Serum bile acid measurement
Options & trade-offs
Management typically involves a combination of dietary modification, medication to reduce copper absorption or promote its excretion, and ongoing monitoring of liver health. The particular combination tends to be shaped by the severity of copper accumulation, the extent of liver damage, and the practical realities of the household. Different dogs and different owners find different approaches more or less workable over the long term.
Low-copper diet
Involves feeding a diet formulated to contain minimal copper, thereby reducing the daily load that the liver must process. Commercial therapeutic diets are available, and home-prepared diets can be formulated with guidance to ensure they meet all other nutritional requirements. The aim is to limit further accumulation while the body slowly mobilises existing stores.
Trade-offs: Palatability can vary, and some dogs are reluctant to accept the change, particularly if the condition is identified before any clinical signs have appeared. Strict adherence over months or years can be challenging in multi-pet households or where treats and table scraps are part of routine life.
Copper chelation therapy
Uses medication—most commonly penicillamine—to bind copper in the body and promote its excretion through urine. The medication is typically given twice daily on an empty stomach. Chelation is often combined with dietary copper restriction to address both existing burden and ongoing intake.
Trade-offs: Penicillamine can cause gastrointestinal upset in some dogs, and long-term use requires periodic monitoring of blood counts and kidney function. The response to chelation varies, and improvement in liver copper levels may take many months to become apparent on repeat biopsy.
Zinc supplementation
Zinc competes with copper for absorption in the intestine, reducing the amount of dietary copper that enters the bloodstream. Zinc acetate is typically used, given between meals to maximise its effect on intestinal cells. It is sometimes used as a sole measure in dogs with mild accumulation or in combination with chelation in more advanced cases.
Trade-offs: Zinc must be given separately from food and other medications to work effectively, which can complicate daily routines. Overdosing can lead to gastrointestinal irritation or interfere with absorption of other essential minerals, so monitoring is needed.
Antioxidant and hepatoprotective supplements
Substances such as vitamin E, S-adenosylmethionine (SAMe), or silymarin are sometimes given to support liver cell health and reduce oxidative damage caused by free copper. These supplements are typically used alongside other measures rather than as standalone treatments.
Trade-offs: The evidence for benefit in copper-associated hepatopathy is limited, and response is difficult to measure without repeat biopsy. Cost and the number of daily tablets can become burdensome, particularly when combined with other medications.
Monitoring and periodic reassessment
Regular blood tests to track liver enzyme activity, liver function, and overall health allow adjustments to treatment over time. Repeat liver biopsy at intervals—often one to two years—can reveal whether copper levels are falling, stable, or continuing to rise, and whether fibrosis is progressing or stabilising.
Trade-offs: Repeated biopsies carry cumulative anaesthetic risk and cost, and not all owners find them acceptable. Blood tests alone cannot confirm changes in liver copper content, so decisions about treatment adjustment may rest on indirect markers.
Common misconceptions
"Copper-associated hepatopathy can be cured by removing all copper from the diet."
Copper is an essential trace element, and eliminating it entirely would cause deficiency and serious health problems. The goal of dietary management is to reduce intake to levels that minimise further accumulation while still meeting the dog's nutritional needs. Even with strict dietary control, copper already stored in the liver may take years to clear, and genetic impairments in excretion mean that some level of ongoing management is usually needed.
"If liver enzymes return to normal, the copper problem has resolved."
Liver enzyme levels can fluctuate and may normalise even while significant copper remains stored in the liver. Enzyme activity reflects current liver cell damage or stress, not the total copper burden. Confirmation that copper levels are falling typically requires repeat liver biopsy and quantification, as blood tests alone cannot measure hepatic copper content.
"Only purebred dogs from known affected breeds develop copper-associated hepatopathy."
While certain breeds carry well-characterised genetic mutations that increase risk, copper accumulation has been observed in mixed-breed dogs and in breeds without identified variants. The condition can arise from a variety of genetic and environmental factors, and any dog presenting with unexplained liver disease may warrant investigation for copper involvement.
Related conditions
Chronic Hepatitis in Dogs
Copper accumulation can drive chronic inflammation in the liver, and chronic hepatitis of other causes can impair bile flow in a way that allows secondary copper retention, making the two conditions difficult to separate in some cases.
Cirrhosis in Dogs
Prolonged copper-associated hepatopathy can lead to progressive scarring and cirrhosis, particularly when copper burden remains high over years; cirrhosis from any cause may also impair copper excretion, creating a cycle of accumulation and damage.
Hepatic Encephalopathy
Advanced liver damage from copper toxicity can reduce the liver's ability to clear ammonia and other toxins from the bloodstream, occasionally leading to neurological signs consistent with hepatic encephalopathy.
Cholangiohepatitis in Cats
Both conditions involve disruption of bile flow and liver inflammation, though cholangiohepatitis occurs primarily in cats and typically has infectious or immune-mediated origins rather than metal accumulation.
Liver Disease in Dogs
Copper-associated hepatopathy is one of several causes of liver disease in dogs; the broader page provides context for interpreting clinical signs and liver enzyme elevations that may prompt investigation for copper burden.
If copper-associated hepatopathy has been identified or is under investigation, it may be useful to explore the broader metabolic and liver-related conditions that can appear in similar contexts, and to understand how liver health intersects with other body systems over time. Conversations about the practical realities of long-term dietary modification, medication schedules, and monitoring frequency can help clarify what fits within the rhythms of daily life. The interplay between genetic risk, environmental factors, and individual variation means that the course in any one dog is difficult to predict with certainty, and ongoing dialogue tends to be part of the landscape.